Last reviewed · How we verify
partial-onset seizures
Approved treatments
- Eslicarbazepine Acetate · Sumitomo Pharma Am
Eslicarbazepine acetate works by stabilizing sodium channels in the brain, reducing the abnormal electrical activity that causes seizures.
Clinical guidelines
- FDA label — 1L
Levetiracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- partial-onset seizures patent landscape — cliff calendar, originator estates, attackable patents
- partial-onset seizures treatment landscape brief
- partial-onset seizures treatment updates RSS
Frequently asked questions about partial-onset seizures
What drugs treat partial-onset seizures?
Tracked treatments include Eslicarbazepine Acetate.
What is the treatment for partial-onset seizures?
Standard treatment for partial-onset seizures includes Eslicarbazepine Acetate. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for partial-onset seizures?
FDA label publishes guidelines for partial-onset seizures. 1 guideline references tracked.
Related
- Treatment landscape: partial-onset seizures patent cliff · partial-onset seizures CI report
- Treatment: Eslicarbazepine Acetate · Sumitomo Pharma Am
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing